CIK 0001159036
- Large accelerated filer
HALOZYME THERAPEUTICS, INC.
Sign in to watch- Ticker
- HALO
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 880488686
- Phone
- +1 858-794-8889
- Business address
- 12390 EL CAMINO REAL, SAN DIEGO, CA, 92130
- Former names
- HALOZYME THERAPEUTICS INC, GLOBAL YACHT SERVICES INC
- 4 Planned sale Director sold 1,625 shares at $66.21 ($107,591)
- 4 Planned sale PRESIDENT AND CEO sold 50,000 shares at an average $68.68 ($3,433,875)
- 4 Grant or award Director acquired 3,796 shares (grant or award)
- 4 Grant or award Director acquired 3,796 shares (grant or award)
- 4 Grant or award Director acquired 3,796 shares (grant or award)
- 4 Grant or award Director acquired 3,796 shares (grant or award)
- 4 Grant or award Director acquired 3,796 shares (grant or award)
- 4 Grant or award Director acquired 6,796 shares (grant or award)
- 4 Planned sale Director sold 1,625 shares at $63.48 ($103,155)
- 4 Planned sale PRESIDENT AND CEO sold 10,000 shares at an average $63.50 ($634,982)
- 4 Derivatives Options or other derivatives
- 4 Planned sale PRESIDENT AND CEO sold 40,000 shares at an average $64.81 ($2,592,237)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale SVP, CHIEF OPERATING OFFICER sold 28,857 shares at an average $67.75 ($1,955,160)
- 4 Planned sale PRESIDENT AND CEO sold 50,000 shares at an average $69.52 ($3,476,157)
- 4 Shares withheld for taxes SVP, CHIEF OPERATING OFFICER gave up 1,037 shares (to pay taxes)
- 4 Shares withheld for taxes SVP, CHIEF LEGAL OFFICER gave up 6,658 shares (to pay taxes)
- 4 Shares withheld for taxes SVP, CHIEF FINANCIAL OFFICER gave up 6,484 shares (to pay taxes)
- 4 Shares withheld for taxes PRESIDENT AND CEO gave up 21,144 shares (to pay taxes)
- 4 Shares withheld for taxes SVP, CHIEF LEGAL OFFICER gave up 9,068 shares (to pay taxes)
Page 2 of 39 · 774 filings